Tukysa
Term · Oncology and biomedicine · MLC-T-ONC-008952
A drug used with other drugs to treat adults with certain types of HER2-positive breast cancer or certain types of HER2-positive colorectal cancer that do not have a mutation (change) in the RAS gene. It is also being studied in the treatment of other types of cancer. Tukysa blocks a protein called HER2, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called tucatinib.
| Identifier | MLC-T-ONC-008952 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | tucatinib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008952",
"term": "Tukysa",
"field": "Oncology and biomedicine",
"definition": "A drug used with other drugs to treat adults with certain types of HER2-positive breast cancer or certain types of HER2-positive colorectal cancer that do not have a mutation (change) in the RAS gene. It is also being studied in the treatment of other types of cancer. Tukysa blocks a protein called HER2, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called tucatinib.",
"synonyms": [
"tucatinib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/tukysa/"
}
Record 16,808 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.